Morgan Stanley Maintains Overweight on NOV, Raises Price Target to $25
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Elizabeth Porter has maintained an Overweight rating on NOV (NYSE:NOV) and raised the price target from $24 to $25.
October 17, 2023 | 2:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Morgan Stanley has maintained an Overweight rating on NOV and raised the price target from $24 to $25, which could lead to a positive market reaction.
The Overweight rating indicates that Morgan Stanley expects NOV to outperform the market. The increase in price target from $24 to $25 suggests that the analyst sees more upside potential in the stock. This could lead to increased investor confidence and a potential rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100